On the morning of May 22, yanghuanming, founder of BGI and academician of the Chinese Academy of Sciences, and zhangchengcai, distinguished professor of the Chinese Academy of Sciences, visited Yinan innovation and entrepreneurship Park for investigation and exchange, accompanied by sundeshi, deputy secretary of the county Party committee and head of the county, the county talent work group, LISIN Nuokang and other relevant responsible comrades.

Academician Yang Huanming and his delegation paid a visit to the park's R&D incubation center, understood the overall layout of the park in detail, focused on the research and research of Lexin Norcom (Shandong) Biomedical Technology Co., Ltd., and highly affirmed the development of the park.

Lixin Nuokang (Shandong) Biomedical Technology Co., Ltd.:

Lexin Nuokang is a wholly-owned subsidiary of Suzhou Lexin Biotechnology Co., Ltd. and is located in the Yinan innovation and entrepreneurship Park in Linyi, Shandong Province. It has a 1500 square meter GMP production base of 100000 and 10000 levels, five internationally advanced production lines for cancer early screening and in vitro diagnostic kits, 15 patents with independent intellectual property rights, FOB for fecal occult blood (changlexin TM), transferrin TF (changweiletm) for early gastric cancer assessment, and FOB for fecal multi-target DNA mutation detection (lichangsheng ®） Etc. Adhering to: the mission is to screen a sample early, save a life, benefit a family and improve people's health! With the strong care and support of the Yinan county Party committee and the county government, the products of the Lexin nuokan colorectal cancer early screening project have been put into production and are geared to the market. As a local large-scale health industry, Lexin Nuokang has always been working hard to give back to the people in Yimeng's hometown and benefit the health of the whole people. It will carry out early colorectal cancer risk screening of the "people's health and benefit the people phase I project".